Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-03 Sale |
2023-02-06 4:15 pm |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President |
12,286 | $1.81 | $22,238 | 797,832 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 7:43 pm |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Operating Officer |
3,394 | $1.86 | $6,313 | 327,144 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 7:43 pm |
Spero Therapeutics Inc. | SPRO | JOSEPH TAMARA L Chief Legal Officer |
3,394 | $1.86 | $6,313 | 324,644 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 7:41 pm |
Spero Therapeutics Inc. | SPRO | Shukla Sath Chief Financial Officer |
9,504 | $1.8279 | $17,372 | 312,517 (Direct) |
View |
| 2022-09-22 Sale |
2022-09-26 3:32 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
1,901,796 | $2.2503 | $4,279,612 | 3,419,435 (Indirect) |
View |
| 2022-08-29 Sale |
2022-08-30 5:00 pm |
Spero Therapeutics Inc. | SPRO | Shukla Sath Chief Financial Officer |
6,017 | $0.8938 | $5,378 | 56,064 (Direct) |
View |
| 2022-04-26 Purchase |
2022-04-28 4:13 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
39,727 | $5.235 | $207,971 | 5,321,231 (Indirect) |
View |
| 2022-03-30 Purchase |
2022-03-31 3:51 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
50,000 | $8.7884 | $439,420 | 5,281,504 (Indirect) |
View |
| 2022-03-14 Purchase |
2022-03-16 4:23 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
23,708 | $7.626 | $180,797 | 5,231,504 (Indirect) |
View |
| 2022-02-28 Purchase |
2022-03-02 3:52 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
44,833 | $9.5293 | $427,227 | 5,207,796 (Indirect) |
View |
| 2022-02-18 Purchase |
2022-02-23 4:24 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
14,828 | $9.2419 | $137,039 | 5,162,963 (Indirect) |
View |
| 2022-01-31 Purchase |
2022-02-01 8:26 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
125,000 | $11.59 | $1,448,263 | 5,148,135 (Indirect) |
View |
| 2022-01-24 Purchase |
2022-01-26 5:12 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
1,599 | $10.89 | $17,418 | 5,023,135 (Indirect) |
View |
| 2022-01-18 Purchase |
2022-01-20 1:07 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
48,488 | $12.41 | $601,964 | 5,021,536 (Indirect) |
View |
| 2022-01-10 Purchase |
2022-01-12 4:43 pm |
Spero Therapeutics Inc. | SPRO | Aquilo Capital Management LLC Aquilo Capital L.P. 10% Owner |
8,867 | $12.93 | $114,609 | 4,973,048 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-12 Option Award |
2023-06-14 08:30 am |
N/A N/A |
Spero Therapeutics Inc. | SPRO | HAMED KAMAL Chief Medical Officer |
140,000 | $0 | 615,957 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 7:43 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Operating Officer |
265,957 | $0 | 327,144 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 7:43 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | JOSEPH TAMARA L Chief Legal Officer |
265,957 | $0 | 324,644 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 7:41 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Shukla Sath Chief Financial Officer |
265,957 | $0 | 312,517 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 7:40 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | HAMED KAMAL Chief Medical Officer |
265,957 | $0 | 475,957 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 7:38 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President |
531,914 | $0 | 810,118 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:16 pm |
N/A 2033-01-03 |
Spero Therapeutics Inc. | SPRO | Tregoning Kathleen Director |
30,943 | $1.29 | 30,943 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:14 pm |
N/A 2033-01-03 |
Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director |
15,471 | $1.29 | 15,471 (Direct) |
View |
Ownership |
2022-11-14 5:05 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | GSK PLC 10% Owner |
0 | $0 | 9,190,606 (Indirect) |
View |
| 2022-09-15 Option Award |
2022-09-19 5:45 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 5:44 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Deshpande Milind Director |
15,000 | $0 | 31,454 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 5:44 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Pottage John C Jr Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 5:44 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Smith Cynthia Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 5:40 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 5:39 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | Tregoning Kathleen Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 5:39 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-09-12 Option Award |
2022-09-14 9:49 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | HAMED KAMAL Chief Medical Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:19 pm |
N/A 2032-02-01 |
Spero Therapeutics Inc. | SPRO | Melnick David A. Chief Medical Officer |
91,204 | $0 | 115,271 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:19 pm |
N/A 2032-02-01 |
Spero Therapeutics Inc. | SPRO | Shukla Sath Chief Financial Officer |
91,204 | $0 | 115,271 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:18 pm |
N/A 2032-02-01 |
Spero Therapeutics Inc. | SPRO | Larkin Cristina Chief Operating Officer |
91,204 | $0 | 116,771 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:18 pm |
N/A 2032-02-01 |
Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President |
321,898 | $0 | 465,934 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:18 pm |
N/A 2032-02-01 |
Spero Therapeutics Inc. | SPRO | Keutzer Timothy Chief Development Officer |
91,204 | $0 | 117,771 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:17 pm |
N/A 2032-02-01 |
Spero Therapeutics Inc. | SPRO | JOSEPH TAMARA L Chief Legal Officer |
91,204 | $0 | 115,271 (Direct) |
View |
| 2022-01-05 Option Award |
2022-01-07 5:13 pm |
N/A 2032-01-05 |
Spero Therapeutics Inc. | SPRO | Tregoning Kathleen Director |
4,428 | $9.03 | 4,428 (Direct) |
View |
| 2022-01-05 Option Award |
2022-01-07 5:09 pm |
N/A 2032-01-05 |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
2,214 | $9.03 | 2,214 (Direct) |
View |
| 2022-01-05 Option Award |
2022-01-07 5:07 pm |
N/A 2032-01-05 |
Spero Therapeutics Inc. | SPRO | VINK PATRICK V.J.J. Director |
2,214 | $9.03 | 2,214 (Direct) |
View |